Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-18 Sale |
2022-05-19 5:58 pm |
Oncocyte Corp | OCX | Yu Li VP Cntrllr/Prncpl Acctng Offcr |
8,128 | $1.14 | $9,266 | 41,872 (Direct) |
View |
| 2022-04-14 Purchase(A) |
2022-04-29 4:33 pm |
Oncocyte Corp | OCX | PURA VIDA INVESTMENTS LLC Kamen Efrem 10% Owner |
5,931,707 | $1.3298 | $7,887,850 | 4,247,291 (Indirect) |
View |
| 2022-04-14 Purchase |
2022-04-18 9:55 pm |
Oncocyte Corp | OCX | PURA VIDA INVESTMENTS LLC Kamen Efrem 10% Owner |
5,931,707 | $1.3298 | $7,887,850 | 4,247,291 (Indirect) |
View |
| 2022-04-14 Purchase |
2022-04-15 6:13 pm |
Oncocyte Corp | OCX | BROADWOOD PARTNERS L.P. BRADSHER NEAL C BROADWOOD CAPITAL INC 10% Owner |
6,003,752 | $1.3325 | $8,000,000 | 59,269,808 (Indirect Direct) |
View |
| 2022-03-25 Purchase |
2022-03-28 8:00 pm |
Oncocyte Corp | OCX | Ross Douglas T. Chief Scientific Officer |
15,000 | $1.4 | $21,000 | 20,317 (Direct) |
View |
| 2022-03-17 Purchase |
2022-03-17 9:27 pm |
Oncocyte Corp | OCX | Paulsen Gisela Chief Operating Officer |
16,500 | $1.198 | $19,767 | 266,500 (Direct) |
View |
| 2022-03-16 Purchase |
2022-03-17 9:26 pm |
Oncocyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
50,000 | $1.283 | $64,150 | 293,212 (Direct) |
View |
| 2022-03-16 Purchase |
2022-03-16 9:08 pm |
Oncocyte Corp | OCX | Redmond Cavan M. Director |
40,000 | $1.189 | $47,560 | 110,863 (Direct) |
View |
| 2022-03-15 Purchase |
2022-03-15 4:19 pm |
Oncocyte Corp | OCX | Levine Mitchell S Chief Financial Officer |
25,000 | $1.166 | $29,150 | 87,080 (Direct) |
View |
| 2021-03-19 Purchase |
2021-03-22 5:17 pm |
OncoCyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
11,000 | $4.7911 | $52,702 | 113,698 (Direct) |
View |
| 2021-02-05 Purchase |
2021-02-09 5:21 pm |
OncoCyte Corp | OCX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C 10% Owner |
600,000 | $4.5 | $2,700,000 | 33,556,113 (Indirect Direct) |
View |
| 2021-01-20 Purchase |
2021-01-22 4:28 pm |
OncoCyte Corp | OCX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C 10% Owner |
1,460,280 | $3.424 | $4,999,999 | 32,356,113 (Indirect Direct) |
View |
| 2020-12-23 Sale |
2020-12-28 9:46 pm |
OncoCyte Corp | OCX | KINGSLEY ALFRED D Director |
900 | $2.55 | $2,295 | 543,494 (Indirect Direct) |
View |
| 2020-12-21 Sale |
2020-12-23 9:12 pm |
OncoCyte Corp | OCX | KINGSLEY ALFRED D Director |
42,800 | $0.30551 | $13,076 | 556,147 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2022-06-13 5:50 pm |
N/A 2031-09-13 |
Oncocyte Corp | OCX | John Anish M. SVP, Finance, and Interim CFO |
0 | $0 | 200,000 (Direct) |
View |
| 2022-05-18 Exercise |
2022-05-19 5:58 pm |
N/A N/A |
Oncocyte Corp | OCX | Yu Li VP Cntrllr/Prncpl Acctng Offcr |
25,000 | $0 | 41,872 (Direct) |
View |
| 2022-04-13 Option Award |
2022-04-15 6:13 pm |
N/A N/A |
Oncocyte Corp | OCX | BROADWOOD PARTNERS L.P. BRADSHER NEAL C BROADWOOD CAPITAL INC 10% Owner |
6,009,634 | $0 | 59,269,808 (Direct) |
View |
| 2022-03-15 Option Award |
2022-03-17 9:29 pm |
N/A 2032-03-15 |
Oncocyte Corp | OCX | Yu Li VP Cntrllr/Prncpl Acctng Offcr |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-03-15 Option Award |
2022-03-17 9:29 pm |
N/A 2032-03-15 |
Oncocyte Corp | OCX | Ross Douglas T. Chief Scientific Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-03-15 Option Award |
2022-03-17 9:27 pm |
N/A 2032-03-15 |
Oncocyte Corp | OCX | Paulsen Gisela Chief Operating Officer |
250,000 | $0 | 266,500 (Direct) |
View |
| 2022-03-15 Option Award |
2022-03-17 9:24 pm |
N/A 2032-03-15 |
Oncocyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
1,410,000 | $0 | 1,410,000 (Direct) |
View |
| 2022-03-15 Option Award |
2022-03-17 9:24 pm |
N/A 2032-03-15 |
Oncocyte Corp | OCX | Sundar Padmavathi Chief Commercial Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2022-03-15 Option Award |
2022-03-17 9:21 pm |
N/A 2032-03-15 |
Oncocyte Corp | OCX | Levine Mitchell S Chief Financial Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-10-14 4:05 pm |
N/A 2031-05-18 |
Oncocyte Corp | OCX | Yu Li VP Cntrllr/Prncpl Acctng Offcr |
160,000 | $0 | 160,000 (Direct) |
View |
Ownership |
2021-10-14 4:05 pm |
N/A 2031-10-04 |
Oncocyte Corp | OCX | Paulsen Gisela Chief Operating Officer |
0 | $0 | 375,000 (Direct) |
View |
| 2021-09-23 Option Award |
2021-09-24 4:56 pm |
N/A 2021-09-30 |
Oncocyte Corp | OCX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C 10% Owner |
573,461 | $0 | 36,814,957 (Direct) |
View |
| 2021-09-23 Exercise |
2021-09-24 4:56 pm |
N/A 2021-09-30 |
Oncocyte Corp | OCX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C 10% Owner |
573,461 | $0 | 36,814,957 (Direct) |
View |
| 2021-09-23 Exercise |
2021-09-24 4:56 pm |
N/A N/A |
Oncocyte Corp | OCX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C 10% Owner |
573,461 | $3.1525 | 36,814,957 (Direct) |
View |
| 2021-07-01 Tax Withholding |
2021-07-02 9:32 pm |
N/A N/A |
OncoCyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
15,834 | $0 | 243,212 (Direct) |
View |
| 2021-07-01 Exercise |
2021-07-02 9:32 pm |
N/A N/A |
OncoCyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
65,000 | $0 | 243,212 (Direct) |
View |
| 2021-06-30 Tax Withholding |
2021-07-02 1:59 pm |
N/A N/A |
OncoCyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
25,873 | $0 | 194,046 (Direct) |
View |
| 2021-05-07 Exercise |
2021-07-02 1:59 pm |
N/A N/A |
OncoCyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
106,221 | $0 | 194,046 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 8:36 pm |
N/A 2031-06-23 |
OncoCyte Corp | OCX | Redmond Cavan M. Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 8:34 pm |
N/A 2031-06-23 |
OncoCyte Corp | OCX | Carter Jennifer L. Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 8:33 pm |
N/A 2031-06-23 |
OncoCyte Corp | OCX | Last Andrew J. Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 8:32 pm |
N/A 2031-06-23 |
OncoCyte Corp | OCX | KINGSLEY ALFRED D Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 8:31 pm |
N/A 2031-06-23 |
OncoCyte Corp | OCX | GRIFFITH MELINDA Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 8:30 pm |
N/A 2031-06-23 |
OncoCyte Corp | OCX | Arno Andrew Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2021-06-11 Exercise |
2021-06-14 8:20 pm |
N/A N/A |
OncoCyte Corp | OCX | Last Andrew J. Director |
6,993 | $3 | 30,170 (Direct) |
View |
| 2021-06-11 Exercise |
2021-06-14 8:20 pm |
2019-02-01 2024-02-01 |
OncoCyte Corp | OCX | Last Andrew J. Director |
6,993 | $0 | 30,170 (Direct) |
View |
Ownership |
2021-05-24 7:19 pm |
N/A N/A |
OncoCyte Corp | OCX | Yu Li VP Cntrllr/Prncpl Acctng Offcr |
0 | $0 | 25,000 (Direct) |
View |
| 2021-04-28 Tax Withholding |
2021-04-30 7:09 pm |
N/A N/A |
OncoCyte Corp | OCX | Levine Mitchell S Chief Financial Officer |
4,620 | $0 | 62,080 (Direct) |
View |
| 2021-04-28 Exercise |
2021-04-30 7:09 pm |
N/A N/A |
OncoCyte Corp | OCX | Levine Mitchell S Chief Financial Officer |
20,000 | $0 | 62,080 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 4:35 pm |
N/A 2031-02-24 |
OncoCyte Corp | OCX | Sundar Padmavathi Chief Commercial Officer |
255,000 | $5.34 | 255,000 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 4:32 pm |
N/A 2031-02-24 |
OncoCyte Corp | OCX | Levine Mitchell S Chief Financial Officer |
255,000 | $5.34 | 255,000 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 4:28 pm |
N/A 2031-02-24 |
OncoCyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer |
500,000 | $5.34 | 500,000 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 4:23 pm |
N/A 2031-02-24 |
OncoCyte Corp | OCX | Ross Douglas T. Chief Medical Officer |
255,000 | $5.34 | 255,000 (Direct) |
View |
| 2020-12-23 Exercise |
2020-12-28 9:46 pm |
N/A 2020-12-28 |
OncoCyte Corp | OCX | KINGSLEY ALFRED D Director |
66,508 | $1.34 | 543,494 (Direct) |
View |
| 2020-12-21 Exercise |
2020-12-23 9:12 pm |
N/A 2020-12-28 |
OncoCyte Corp | OCX | KINGSLEY ALFRED D Director |
58,492 | $1.34 | 556,147 (Direct) |
View |
| 2020-12-11 Option Award |
2020-12-15 06:31 am |
N/A N/A |
OncoCyte Corp | OCX | HESTERBERG LYNDAL K. CSO |
6,603 | $0 | 7,477 (Direct) |
View |
| 2020-12-11 Option Award |
2020-12-15 06:29 am |
N/A N/A |
OncoCyte Corp | OCX | Arno Andrew Director |
9,602 | $0 | 112,049 (Direct) |
View |